Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Augmentation of Clozapine With Paliperidone in the Treatment of Resistant Schizophrenia Randomized Controlled Study

NCT01279213 is registered in ClinicalTrials.gov with Universidad Nacional de Rosario as lead sponsor.

NCT NCT01279213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01279213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Augmentation of Clozapine With Paliperidone in the Treatment of Resistant Schizophrenia Randomized Controlled Study
Lead sponsor
Universidad Nacional de Rosario
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2009
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychotic disorder, schizophrenia, schizophrenic disorders